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Ciprofloxacin is a worldwide-used, broad-spectrum antibiotic with low water-solubility [1]. To 
earn higher solubility, and better bioavailability, nanofibers were fabricated as an amorphous 
solid dispersion with the polymer, polyvinylpyrrolidone (PVP). For the production, needle and 
needleless electrospinning methods were used [2]. The fiber size and morphology were 
observed by scanning electron microscopy (SEM). Physicochemical properties were 
characterized by X-ray powder diffraction (XRPD), differential scanning calorimeter (DSC), and 
Fourier-transform infrared spectroscopy (FTIR). The results proved the amorphous state of the 
CIP inside the nanofibrous mats. The solubility, in vitro dissolution rate, and in vitro diffusion 
were remarkably higher in the case of the nanofibers compared with the CIP powder or the 
physical mixture of the two components. The solubility of the CIP demonstrated a significant 
increase both in water (pH 6.3) and phosphate buffer solution (pH 7.4). In addition, fast-
dissolving formulations were developed, while 94±6% of the CIP was released in the first 5 
min. Moreover, in vitro diffusion from pH 6.8 to pH 7.4 also showed a notable increase. The 
stability of the nanofibrous samples was studied by SEM and in vitro dissolution. In conclusion, 
fast-dissolving formulations were built up which can be further investigated to develop 
appropriate pharmaceutical forms. 
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